… the time that patients first present with a brain tumour. Differentiating a treatment response
from a post-treatment-related effect using … (grades 3 and 4), which are the malignant gliomas. …

… ; these cells are critical regulators of immune and therapeutic responses to GBM. Here, we
will … to promote radiotherapy for glioma treatment induced cytotoxicity to glioma cells under …

… As such, we recorded ECoG activity in 12 nonaphasic patients with malignant gliomas on
the … To do so, we performed cortical language mapping in all 12 participants using direct …

… ), the assessment of treatment response to systemic treatment options such as … response
to antiangiogenic therapy with bevacizumab in patients with recurrent malignant glioma…

… This may account for the frequently observed inter-patient variability to treatment response.
Indeed, … The premise of our hypothesis rests in being able to map these modules in clinical …

… malignant glioma remain unknown, as the low response and persistence of treatments in
glioma … Given this, individualized treatment and real-time monitoring of treatment response are …

… patients, metacluster frequencies for each primary tumor were fed into the t-stochastic neighbor
embedding (t-SNE) dimensionality reduction algorithm to produce a map of … The glioma …

… To delineate genes important for defining and maintaining the GSC state, we mapped SE
loci across a large panel of patient-derived GSC cultures. Our analysis revealed 8,533 distinct …

… Malignant gliomas typically contain both neoplastic cells and … ; and (iii) glioblastoma NOS,
for which full IDH evaluation … differ in prognosis and therapy response. Primary glioblastomas …

… tissue, and cortical mapping in awake patients.Tumour specimens … glioblastoma diagnosis
and monitor treatment response? … neurocognitive dysfunction in patients with diffuse glioma: a …